RCKT (STOCKS)
Rocket Pharmaceuticals, Inc. Common Stock
$3.620700
+0.130700 (+3.74%)
Prev close: $3.490000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Gaurav D. Shah
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $396.12M
- Employees
- 299
- P/E (TTM)
- -1.81
- P/B (TTM)
- 1.42
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
7
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.38 | $-0.46 | +0.0824 | +17.82% |
|
Sep 2025 (Q3)
|
$-0.45 | $-0.52 | +0.0651 | +12.64% |
|
Jun 2025 (Q2)
|
$-0.59 | $-0.57 | -0.0222 | -3.91% |
|
Mar 2025 (Q1)
|
$-0.56 | $-0.63 | +0.0661 | +10.56% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $231.75M |
| Research and Development | $142.02M |
| Other Operating Expenses | $89.73M |
| Operating Income/Loss | -$231.75M |
| Income/Loss From Continuing Operations After Tax | -$223.12M |
| Income/Loss From Continuing Operations Before Tax | -$223.12M |
| Income Tax Expense/Benefit | $0.00 |
| Interest Expense, Operating | $1.89M |
| Net Income/Loss | -$223.12M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$223.12M |
| Net Income/Loss Available To Common Stockholders, Basic | -$223.12M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.01 |
| Diluted Earnings Per Share | -$2.01 |
| Basic Average Shares | 111,123,770 |
| Diluted Average Shares | 111,123,770 |
| Assets | $330.45M |
| Current Assets | $192.73M |
| Cash | $188.90M |
| Other Current Assets | $3.83M |
| Noncurrent Assets | $137.72M |
| Fixed Assets | $28.17M |
| Intangible Assets | $25.15M |
| Other Non-current Assets | $84.40M |
| Liabilities | $53.23M |
| Current Liabilities | $30.21M |
| Wages | $12.29M |
| Other Current Liabilities | $17.91M |
| Noncurrent Liabilities | $23.02M |
| Equity | $277.22M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $277.22M |
| Liabilities And Equity | $330.45M |
| Net Cash Flow From Operating Activities | -$190.01M |
| Net Cash Flow From Operating Activities, Continuing | -$190.01M |
| Net Cash Flow From Investing Activities | $103.77M |
| Net Cash Flow From Investing Activities, Continuing | $103.77M |
| Net Cash Flow From Financing Activities | $148.00K |
| Net Cash Flow From Financing Activities, Continuing | $148.00K |
| Net Cash Flow | -$86.10M |
| Net Cash Flow, Continuing | -$86.10M |
| Comprehensive Income/Loss | -$223.22M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$223.22M |
| Other Comprehensive Income/Loss | -$223.22M |